<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-vetsci-02-00456">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vahlenkamp</surname>
    <given-names>T.W.</given-names>
   </name>
   <name>
    <surname>De Ronde</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Balzarini</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Naesens</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>De Clercq</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>van Eijk</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Horzinek</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Egberink</surname>
    <given-names>H.F.</given-names>
   </name>
  </person-group>
  <article-title>(r-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>1995</year>
  <volume>39</volume>
  <fpage>746</fpage>
  <lpage>749</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.39.3.746</pub-id>
  <?supplied-pmid 7793884?>
  <pub-id pub-id-type="pmid">7793884</pub-id>
 </element-citation>
</ref>
